Mahtiyan, Elham
MD, Psychiatrist, fellowship in Psychotherapy, Psychiatry and Behavioral Sciences Research Center, Addiction Institute and Department of Psychiatry; Faculty of Medicine Mazandaran University of Medical Sciences, Sari, Iran.
[ 1 ] - Evaluation of the Efficacy and Safety of Adding Pregabalin to Antipsychotic Treatment in Patients With Chronic Schizophrenia: A Double-blind Placebo-controlled Clinical Trial
Objectives: This study aims to evaluate the efficacy and safety of adding pregabalin to standard antipsychotic treatment in patients with chronic schizophrenia. Methods: In this randomized, double-blind, placebo-controlled clinical trial, participants were 48 male inpatients aged 18-65 years with chronic schizophrenia but with clinically stable conditions. They were randomly divided into two grou…
نویسندگان همکار